Skip to content

Chlamydia trachomatis IgG Control Serum BC1372G



  • Virion/Serion Diagnostic Kit Control for research use (RUO)
  • Chlamydia trachomatis IgG Control Serum
  • Applications: ELISA
  • IgG control serum
  • Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
  • 3 mL
Weight1 lbs
Dimensions9 × 5 × 2 in

Chlamydia trachomatis reactive IgG

species reactivity

Chlamydia trachomatis



assay type

Indirect & quantitative

available size

3 mL

Chlamydia trachomatis IgG Control Serum BC1372G

Research area
Infectious Disease
Store at 2-8°C.
Associated products
Chlamydia trachomatis EB + RB Antigen (BA1372VSER)
Chlamydia trachomatis MOMP Antigen (BA1372VSR2)
Chlamydia trachomatis IgA Control Serum (BC1372A)
Chlamydia trachomatis IgG Control Serum (BC1372G)
Chlamydia trachomatis IgM Control Serum (BC1372M)
Chlamydia trachomatis IgA ELISA Kit (ESR1372A)
Chlamydia trachomatis IgG ELISA Kit (ESR1372G)
Chlamydia trachomatis IgM ELISA Kit (ESR1372M)
Chlamydia IgA ELISA Kit (ESR137A)
target relevance
Chlamydia trachomatis
Structure and strains
Chlamydia trachomatis, commonly known as chlamydia, is a bacterium that causes chlamydia, which can manifest in various ways, including: trachoma, lymphogranuloma venereum, nongonococcal urethritis, cervicitis, salpingitis, pelvic inflammatory disease. C. trachomatis is the most common infectious cause of blindness and the most common sexually transmitted bacterium.

Different types of C. trachomatis cause different diseases. The most common strains cause disease in the genital tract, while other strains cause disease in the eye or lymph nodes. Like other Chlamydia species, the C. trachomatis life cycle consists of two morphologically distinct life stages: elementary bodies and reticulate bodies. Elementary bodies are spore-like and infectious, whereas reticulate bodies are in the replicative stage and are seen only within host cells.
Pathogens Chlamydia trachomatis is one of the most common sexually transmitted bacterial pathogens. Depending on the serovar, the may infect epithelial cells of the urogenital and respiratory tract as well as the conjunctiva.

Chlamydia trachomatis infections may be asymptomatic in 70% of females and in up to 50% of males. Untreated, infections may result in serious damage and complications. The serovars A to C cause ceratoconjunctivits. Chronic infections during childhood can result in trachoma or blindness. Serovars D to K are pathogens of the urogenital tract, responsible for urethritis, proctitis and cervicitis. Salpinigits, endomitritis and perihepatitis are frequently the consequence of untreated cervicitis. Occasionally, tubal obstructions and ectopic pregnancy, which belong to the most common reasons for infertility in women, may occur. Furthermore, the risk of a premature delivery for infected pregnant women is also increased. In addition to urethritis, epidiymitis and prostatitis, which may lead to infertility, are possible consequences for men.
Detection and diagnosis
Following an urogenital infection, the pathogen may migrate to the upper genital tract. This can cause difficulties in direct pathogen detection via cell culture or PCR. In such cases, serological analysis is essential for the diagnosis of Chlamydia trachomatis infections. Formerly, the Microimmunofluorescence test (MIF) has been accepted as the reference method. More recently, standardized and automated ELISA tests are used in routine laboratories.



Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.



relevant to this product
BC1372G protocol


No results found


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.